Eli Lilly Market Cap History



Below is a table of the Eli Lilly market cap history going back to 2/12/2010:

Date LLY Market Cap
2/12/201039.15B
4/20/201042.12B
7/20/201040.66B
10/20/201041.52B
2/15/201139.90B
4/20/201141.83B
7/20/201144.19B
10/20/201144.70B
2/15/201244.76B
4/20/201246.31B
7/20/201251.26B
10/20/201261.34B
2/15/201360.79B
4/30/201362.39B
7/20/201357.01B
10/23/201356.68B
2/14/201460.69B
4/21/201468.13B
7/21/201471.11B
10/20/201470.26B
2/13/201578.40B
4/20/201580.36B
7/20/201597.41B
10/19/201588.92B
4/18/201685.24B
7/18/201688.25B
10/17/201686.69B
2/13/201785.81B
4/24/201792.04B
7/17/201792.09B
10/23/201795.99B
2/14/201884.39B
4/23/201887.05B
7/23/201895.46B
11/2/2018113.08B
2/13/2019123.89B
4/29/2019116.11B
7/29/2019104.96B
10/21/2019103.61B
2/13/2020135.61B
7/27/2020153.51B
10/26/2020135.55B
2/12/2021198.67B
4/27/2021174.74B
7/30/2021232.93B
10/22/2021233.17B
2/18/2022228.86B
4/26/2022268.73B
8/1/2022308.00B
10/28/2022341.97B
2/17/2023312.08B
4/24/2023363.90B
8/3/2023426.39B
2/16/2024743.09B

Also see: LLY Shares Outstanding History
and LLY YTD Return
Eli Lilly Historical Market Cap:
+23.36% CAGR
Eli Lilly Historical Market Cap: +23.36% CAGR

Mouse over chart for data details
2/12/2010 ...2/16/2024
Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products and other therapies. Co.'s diabetes products include: Basaglar®, a long-acting human insulin analog for the treatment of diabetes; and Trajenta®, for the treatment of type 2 diabetes. Co.'s oncology products include: Alimta®, for treatment of patients with non-squamous cell histology and no epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor aberrations. We show 54 historical shares outstanding datapoints in our LLY shares outstanding history coverage, used to compute LLY market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing Eli Lilly market cap history over the course of time is important for investors interested in comparing Eli Lilly's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of Eli Lilly versus a peer is one thing; comparing Eli Lilly market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like Eli Lilly can fluctuate over the course of history. With this page we aim to empower investors researching Eli Lilly by allowing them to research the Eli Lilly market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree LLY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Eli Lilly (LLY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

LMAT Market Cap History
LMNX Market Cap History
LNSR Market Cap History
LNTH Market Cap History
LOXO Market Cap History
LPCN Market Cap History
LPNT Market Cap History
LPTX Market Cap History
LQDA Market Cap History
LRMR Market Cap History
More Healthcare companies »

 

Eli Lilly Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.